Skip to main content
Veterinary Medicines

LILIMICINA Suspensão injetável para equinos, bovinos, suínos, cães e gatos

Not authorised
  • Dihydrostreptomycin sulfate
  • Benzylpenicillin procaine

Product identification

Medicine name:
LILIMICINA Suspensão injetável para equinos, bovinos, suínos, cães e gatos
Active substance:
  • Dihydrostreptomycin sulfate
  • Benzylpenicillin procaine
Target species:
  • Cattle
  • Pig
  • Dog
  • Cat
  • Horse (non food-producing)
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Dihydrostreptomycin sulfate
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Benzylpenicillin procaine
    114.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        30
        day
      • Milk
        4
        day
    • Pig
      • Meat and offal
        30
        day
    • Dog
    • Cat
    • Horse (non food-producing)
  • Intramuscular use
    • Cattle
      • Meat and offal
        30
        day
      • Milk
        4
        day
    • Pig
      • Meat and offal
        30
        day
    • Horse (non food-producing)
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RA01
Authorisation status:
  • Revoked
Authorised in:
  • Portugal
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ceva Saude Animal Produtos Farmaceuticos E Imunologicos Lda.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Sante Animale
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 1442/01/21NFVPT
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 4/07/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."